ADAP - Adaptimmune Q4 2022 Earnings Preview
- Adaptimmune ( NASDAQ: ADAP ) is scheduled to announce Q4 earnings results on Monday, March 6th, before market open.
- The consensus EPS Estimate is -$0.25 and the consensus Revenue Estimate is $5.08M (+262.9% Y/Y).
- Over the last 1 year, ADAP has beaten EPS estimates 75% of the time and has beaten revenue estimates 25% of the time.
For further details see:
Adaptimmune Q4 2022 Earnings Preview